文献速递关节外科

全膝关节置换术中抗生素骨水泥的经济学分析:成本增加而未降低感染率

The Economics of Antibiotic Cement in Total Knee Arthroplasty: Added Cost with No Reduction in Infection Rates.
PubMed 文献 · J Arthroplasty · 2019-04-26

该回顾性研究纳入2015至2017年两家医院连续接受骨水泥型初次全膝关节置换术的2511例患者,比较抗生素骨水泥(ALBC)与普通骨水泥在假体周围感染(PJI)率、并发症和费用上的差异。作者结论认为常规使用ALBC在初次全膝关节置换术中不具有成本效益,每例增加299美元费用而未降低PJI率,需进一步研究确定高危患者中选择性使用是否合理。

要点

  • ALBC组与普通骨水泥组PJI率分别为0.56%和0.14%,差异无统计学意义(P=0.0662)。
  • 若要使ALBC额外成本合理,需每101例中预防1例感染。

核心结论

  • 常规使用ALBC在初次全膝关节置换术中不具有成本效益,每例增加299美元费用而未降低PJI率。
  • 需进一步研究确定高危患者中选择性使用ALBC是否合理。

研究设计与样本

  • 回顾性审查2015至2017年本机构内两家医院连续接受骨水泥型初次全膝关节置换术的患者。
  • 共纳入2511例患者,其中1077例(43%)接受ALBC,其余接受普通骨水泥。
  • 比较两组人口学特征、合并症、费用和PJI率,并进行多因素回归分析确定ALBC对PJI率的独立影响。

主要发现

  • ALBC组与普通骨水泥组PJI率分别为0.56%和0.14%,差异无统计学意义(P=0.0662)。
  • ALBC组与普通骨水泥组并发症发生率分别为1.2%和1.6%,差异无统计学意义(P=0.3968)。
  • ALBC组骨水泥费用为416美元,普通骨水泥组为117美元,差异有统计学意义(P<0.0001)。
  • 因PJI再入院患者的90天整体诊疗索赔费用为49341美元,高于无PJI再入院患者的19032美元,差异有统计学意义(P<0.001)。

关键数值与推荐

  • ALBC对感染率无影响(P=0.0894)。
  • 要使ALBC的额外成本合理,需每101例患者中预防1例感染。

临床怎么用

  • 作者结论认为常规使用ALBC在初次全膝关节置换术中不具有成本效益。
  • 作者提出需进一步研究确定高危患者中选择性使用ALBC是否合理。

局限性

  • 需进一步研究确定高危患者中选择性使用ALBC是否合理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To reduce the substantial clinical and financial burden of periprosthetic joint infection (PJI), some surgeons advocate for the use of antibiotic-loaded bone cement (ALBC) in primary total knee arthroplasty (TKA), although its effectiveness continues to be debated in the literature. The purpose of this study was to determine whether the routine use of ALBC is cost-effective in reducing PJI after primary TKA. METHODS: We retrospectively reviewed a consecutive series of patients undergoing cemented primary TKA at two hospitals within our institution from 2015 to 2017. We compared demographics, comorbidities, costs, and PJI rates between patients receiving ALBC and plain cement. We performed a multivariate regression analysis to determine the independent effect of ALBC on PJI rate. We calculated readmission costs for PJI and reduction in PJI needed to justify the added cost of ALBC. RESULTS: Of 2511 patients, 1077 underwent TKA with ALBC (43%), with no difference in PJI rates (0.56% vs 0.14%, P = .0662) or complications (1.2% vs 1.6%, P = .3968) but higher cement costs ($416 vs $117, P < .0001) and overall procedure costs ($6445 vs $5.968, P < .0001). ALBC had no effect on infection rate (P = .0894). Patients readmitted with PJI had higher overall 90-day episode-of-care claims costs ($49,341 vs $19,032, P < .001). To justify additional costs, ALBC would need to prevent infection in one of every 101 patients. CONCLUSION: Routine use of ALBC in primary TKA is not cost-effective, adding $299 to the cost of episode of care without a reduction in PJI rate. Further study is needed to determine whether select use of ALBC would be justified in high-risk patients.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Yayac M, Rondon AJ, Tan TL, et al. The Economics of Antibiotic Cement in Total Knee Arthroplasty: Added Cost with No Reduction in Infection Rates. J Arthroplasty. 2019. PMID: 31122848. doi:10.1016/j.arth.2019.04.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。